SB2838 creates a new regulatory framework in the Illinois Insurance Code for “hearing care plans” and “discounted hearing care plans.” It defines key terms such as hearing care organization, hearing instrument professional, covered items, covered services, prescription hearing aid, and routine hearing care services, and it excludes over-the-counter hearing aids from the bill’s covered-item definition. The bill applies to hearing care plans and discounted hearing care plans issued, delivered, amended, or renewed on or after the effective date, and it sets out disclosure, billing, and plan-document requirements for insurers and administrators.
The bill prohibits hearing care organizations from requiring hearing instrument professionals to accept plan-set fees for noncovered items and services, and it requires providers who do not accept those fees to post a conspicuous notice or provide equivalent written notice. It also requires hearing care benefits and noncovered items/services to be clearly communicated in writing, bars organizations from misrepresenting discount benefits as funded benefits, and requires disclosure when a hearing aid manufacturer owns or operates the organization. The bill further extends these requirements to subcontractors and makes administrators of hearing care plans and discounted hearing care plans subject to the new section.
SB2838 amends the Illinois Insurance Code by adding new Sections 356z.88, 370u, and 511.119, and it also amends the Health Maintenance Organization Act and the Limited Health Service Organization Act to incorporate compliance with the new hearing-care provisions. In practical terms, it imposes new disclosure, contract, and consumer-information obligations on insurers, HMOs, administrators, hearing care organizations, and related subcontractors that offer hearing-related coverage or discount programs. The bill also updates the list of Insurance Code provisions applicable to HMOs and limited health service organizations, and it takes effect January 1, 2027.
No committee transcripts or recorded votes were provided, so there is no documented floor or committee debate to gauge support or opposition. Based on the bill text, the measure appears consumer-protection oriented, with an emphasis on transparency, preventing misleading discount marketing, and clarifying provider reimbursement rules. The absence of recorded votes or discussion means the public sentiment in the legislative record cannot be directly assessed from the materials provided.
The main points of potential contention are the bill’s restrictions on how hearing care organizations and administrators structure provider fees and market discount plans. Hearing instrument professionals may support the bill’s protection against being forced to accept plan-set fees for noncovered services, while insurers or plan administrators may view the notice, disclosure, and contract requirements as burdensome. Another likely issue is the manufacturer-ownership disclosure requirement, which could be seen as increasing transparency by consumer advocates but as adding compliance obligations by industry stakeholders. The bill also distinguishes funded benefits from discount benefits and excludes over-the-counter hearing aids from covered items, which may affect how plans design and advertise hearing coverage.